Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN
Perrin Steven received 152,353 Eledon Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jul 31, 2026 · Filed Aug 4, 2026
On Jul 31, 2026, Perrin Steven (Director, President) received 152,353 Eledon Pharmaceuticals, Inc. shares as an award, leaving 81,215 shares. Filed Aug 4, 2026 (Form 4).
- Awarded
- 152,353 shares
- Holding after
- 81,215 shares
- Trading plan
- No
- Role
- Director, President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common Stock | Award | 152,353 | 153,353 | Direct | |
| Jul 31, 2026 | Common Stock | Shares withheld for tax | 72,138 | US$3.38 | 81,215 | Direct |
Source
Related
- Eledon Pharmaceuticals, Inc.
- Perrin Steven
- Eledon Pharmaceuticals, Inc. shareholders
- Form 4 · Gros David-Alexandre C · Aug 4, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026